No Data
Livzon Pharma's Generic Drug Receives Regulatory Green Light
Express News | Livzon Pharmaceutical - Unit Received Approval Notice for Supplementary Application for Leuprorelin Acetate Microspheres for Injection
Livzon Pharma Announces Board and Committee Structure
Livzon Pharma (01513): Yu Xiong resigns from the position of director.
Livzon Pharma (01513) announced that on October 14, 2024, they received a written resignation letter from Mr. Yu Xiong. Due to...
China Approves Livzon Pharmaceutical's Injection for Endometriosis
Livzon Pharmaceutical Gets Nod to Register Endometriosis Treatment Drug
The Market Doesn't Like What It Sees From Livzon Pharmaceutical Group Inc.'s (SZSE:000513) Earnings YetNo Data
No Data
